Latest Breaking News On - Etero 039s nirmacom paxlovid to get who pre qualification - Page 1 : vimarsana.com

Hetero, India’s leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral antiviral treatment candidate nirmatrelvir. This is the first prequalification for a generic version of Pfizer’s COVID-19 oral antiviral drug

Charles goreVamsi krishna bandiHetero group of companiesWorld health organization prequalification of medicines programWorld health organization prequalificationMedicines programManaging directorHetero groupMedicines patent poolExecutive directorEmergency use authorizationDrugs controller generalHetero 039s nirmacomEtero 039s nirmacom world 1st generic covid oral drugEtero 039s nirmacom paxlovid to get who pre qualification